维普期刊资源整合服务平台（V6.5）

194篇 您的检索式：作者名="Farlow"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Rivastigmine transder-mal patch skin tolerability : Results of a 1 -year clinical trial in patientswith mild-to-moderate Alzheimer’s disease显示文摘	Cummings JL Farlow MH Meng X	2010	Clin Drug Investig2010，，：	1
2	Fratwisella tularensis strain typing using multiple- locus, variable- number tandem repeat analysis 显示文摘	Farlow J Smith KL Wong J	2001	J Clin Microbiol2001，39，9：	1
3	A randomized, double-blind, pla- cebo--controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type 显示文摘	Schneider LS DeKosky ST Farlow MR	2005	Curt Alzheimer Res2005，2，5：	1
4	Impact of APOE in mild cogni- tive impairment 显示文摘	Farlow MR He Y Tekin S	2004	Neurology2004，63，10：	1
5	Worldwide genetic relationships among Francisella tularensis isolates determined by multiple- Incus variable- number tandem repeat analysis 显示文摘	Johansson A Farlow J Larsson P	2004	J Bacteriol2004，186，17：	1
6	Evidence for native-defect donors in n-type ZnO显示文摘	Look D C Farlow G C Reunchan P	2005	Phys Rev Lett2005，95，22：	1
7	Clinical pharmacokinetics of galantamine显示文摘	Farlow MR	2003	Clin Pharmacokinet2003，42，15：	1
8	Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review 显示文摘	KURZ A FARLOW M LEFEVRE G	2009	3(5): 799-8052009，3，5：	1
9	A critical a- nalysis of new molecular targets and strategies for drug de- velopments in Alzheimer's disease 显示文摘	Lahiri DK Farlow MR Sambamurti K	2003	Curr Drug Targets2003，4，：	1
10	Pharmaeokinetie profiles of current therapies for Alzheimer' s disease: implications for switching to galantamine显示文摘	Farlow MR	2001	Clin Ther2001，23，：	1
11	Efficacy of rivastigmine on executive function in patients with Parkinson′s disease dementia显示文摘	Schmitt FA Farlow MR Meng X		0，，：	1
12	Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial显示文摘	TARIOT P N FARLOW M R GROSSBERG G T	2004	JAMA2004，291，3：	1
13	The hydrogenation of carbon dioxide and a correction of the reported synthesis of urethans显示文摘	Farlow Mark W Adklns Homer	1935	Journal of the American Chemical Society1935，57，：	1
14	Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors 显示文摘	Gauthier S Emre M Farlow MR	2003	Curr Med Res Opin2003，19，8：	1
15	NMDA receptor antagonists:A new therapeutic approach for Alzheimer's disease显示文摘	Farlow MR	2004	Geratrics2004，59，6：	1
16	Memantine treatment in patients with moderate to severe Alzhcimer disease already receiving donepezil: a randomized controlled trial显示文摘	Tariot PN Farlow MR Grossberg GT	2004	JAMA2004，291，3：	1
17	Phase 3 trials of solanez- umab and bapineuzumab for Alzheimer~s disease 显示文摘	Doody RS Farlow M Aisen PS	2014	N Engl J Med2014，370，15：	1
18	Riv- astigmine: an open-label, observational study of safety and effec- tiveness in treating patients with Alzheimer's disease for up to 5 years显示文摘	FARLOW MR LILLY ML ENA713 B352 STUDY GROUP	2005	BMC Geriatr2005，19，5：	1
19	High levels of Alzheimer be- ta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression 显示文摘	Sokol D K Chen D Farlow M R	2006	J Child Neurol2006，21，6：	1
20	A 24 week,doubie blind,placebo controlled trial of donepezilin with Alzheimer disease Donepezilin Study Group显示文摘	Rogers SL Farlow MR Doody RS	2003	Neurology2003，50，1：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示